|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-04
|
$342,938
|
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$1,180
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$600
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$1,256
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$2,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$2,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$26,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$9,108
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$26,513
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$361,715
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126-10538
|
$84,763
|
$42,382
|
Trabert, Britton
|
DCEG (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$65,844
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
|
5U24CA209837-02
|
$630,034
|
|
SHOGHI, KOORESH
|
WASHINGTON UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$2,500
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$35,000
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$17,207
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using [6-13C,6-15N3]-L-Arginine for the molecular imaging of in vivo tumor arginase flux, and towards understanding the role of arginase isoforms in cancer metabolism.
|
1F30CA225174-01
|
$45,891
|
|
CHO, ANDREW
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
5R21CA216756-02
|
$224,460
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
uSHEAR Technology for Cancer Cell Purificaiton
|
5R21CA202849-03
|
$225,649
|
|
GARCIA, ANDRES
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-03
|
$387,731
|
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S3
|
$2,156,000
|
$86,240
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding the consequences of oncogenic mutations on FGFR signaling
|
5F31CA216915-02
|
$44,524
|
|
RYAN, MOLLY
|
YALE UNIVERSITY
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
2U01CA164973-06
|
$3,176,130
|
$317,613
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$14,819
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Training Program in Basic Cancer Research
|
5T32CA009171-42
|
$548,195
|
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-12
|
$468,471
|
$159,280
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Training in Interprofessional Education for Palliative Care in Oncology
|
5R25CA203637-02
|
$293,452
|
|
PFEIFER, MARK
|
UNIVERSITY OF LOUISVILLE
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-33
|
$570,788
|
$142,697
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
Time-Restricted Feeding and Breast Cancer
|
5R01CA196853-03
|
$354,563
|
|
WEBSTER, NICHOLAS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Time-of-Flight PET for Improved Whole-Body Imaging
|
5R01CA113941-13
|
$535,524
|
|
KARP, JOEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
|
5R01CA205150-03
|
$605,252
|
|
HEYMACH, JOHN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of tumor derived exosomes in bone metastasis of prostate cancer
|
1F30CA225133-01
|
$38,971
|
|
HENRICH, STEPHEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The role of the p63-RBM38 loop in tumor suppression
|
5R01CA195828-03
|
$359,138
|
|
CHEN, XINBIN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The Role of RHOA in Diffuse Gastric Cancer
|
1R01CA224428-01
|
$677,302
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
The role of PLK1 in prostate cancer
|
5R01CA191002-03
|
$348,844
|
|
FU, ZHENG
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
The role of p53 in constraining pro-tumorgenic reprogramming
|
5F32CA203146-03
|
$61,174
|
|
HOULIHAN, SHAUNA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role of mRNA methylation in the progression of endometrial cancer
|
1F32CA221007-01
|
$56,694
|
$56,694
|
HARADA, BRYAN
|
UNIVERSITY OF CHICAGO
|
|
The role of CADM1 in malignant melanoma
|
5K99CA207855-02
|
$109,440
|
|
HARTSOUGH, EDWARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
The role of butyrate-producing bacteria in CIMP colorectal cancer tumorigenesis
|
5R01CA205028-02
|
$373,092
|
|
WILLIAMS, BRENT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Abl Kinase Signaling in HER2+ Breast Cancer Brain Metastasis
|
1F31CA224952-01
|
$44,524
|
|
MCKERNAN, COURTNEY
|
DUKE UNIVERSITY
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The NYU Women's Health Study
|
5UM1CA182934-03
|
$694,206
|
$138,841
|
ZELENIUCH-JAQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
|
5R01CA207031-02
|
$366,000
|
|
CHIAO, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Involvement of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma in vivo
|
1F31CA210485-01A1
|
$44,524
|
|
YUAN, SHAOPENG
|
ROCKEFELLER UNIVERSITY
|
|
The Effects of Obesity on the Efficacy of Immunotherapy
|
1F30CA224559-01
|
$29,204
|
|
DUDZINSKI, STEPHANIE
|
VANDERBILT UNIVERSITY
|
|
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
|
5R01CA217207-02
|
$489,796
|
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Uterine for this search: $18,116,282
|